title: [Late sodium current and calcium overload--pathogenesis and adequate treatment].
authors.affiliation: Abteilung Kardiologie und Pneumologie, Herzzentrum, Georg-August-Universität Göttingen. jacobshagen@med.uni-goettingen.de
authors.forename: C
authors.initials: C
authors.lastname: Jacobshagen
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology*; D001281:Atrial Fibrillation / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D001552:Benzazepines / Q000627:therapeutic use; D002118:Calcium / Q000097:blood*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology*; D004562:Electrocardiography / Q000187:drug effects; D004730:Endothelium, Vascular / Q000503:physiopathology; D054144:Heart Failure, Diastolic / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D006934:Hypercalcemia / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology*; D000077550:Ivabradine; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology*; D009566:Nitrates / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D000069458:Ranolazine; D012964:Sodium / Q000378:metabolism; D015222:Sodium Channels / Q000187:drug effects / Q000502:physiology*; D019831:Sodium-Calcium Exchanger / Q000187:drug effects / Q000502:physiology*
chemical_list: D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D001552:Benzazepines; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D009566:Nitrates; D010879:Piperazines; D015222:Sodium Channels; D019831:Sodium-Calcium Exchanger; D000077550:Ivabradine; D012964:Sodium; D000069458:Ranolazine; D002118:Calcium